| Mr Troy A Tarpley, AAC | |
|
300 University Blvd, Round Rock, TX 78665-1032 | |
| (512) 509-0100 | |
| Not Available |
| Full Name | Mr Troy A Tarpley |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 14 Years |
| Location | 300 University Blvd, Round Rock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720388903 | NPI | - | NPPES |
| AA72 | Other | FL | LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | AA72 (Florida) | Secondary |
| 367H00000X | Anesthesiologist Assistant | 1171 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baylor Scott & White Medical Center Pflugerville | Pflugerville, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Scott And White Clinic | 8123923604 | 2131 |
News Archive
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history.
Andrew Tsin, professor of biology in the UTSA College of Sciences, has been named a Gold Fellow of the Association for Research in Vision and Ophthamology for his dedication and exemplary contributions in the field. Tsin will receive the honor at the 2015 ARVO Annual Meeting, May 3-7 in Denver.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new University of Liverpool study, published in Wiley Brain and Behaviour, examines the factors that influence how a person adapts to visual field loss following stroke.
› Verified 9 days ago
| Entity Name | Scott & White Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093779704 PECOS PAC ID: 8123923604 Enrollment ID: O20031223000640 |
News Archive
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history.
Andrew Tsin, professor of biology in the UTSA College of Sciences, has been named a Gold Fellow of the Association for Research in Vision and Ophthamology for his dedication and exemplary contributions in the field. Tsin will receive the honor at the 2015 ARVO Annual Meeting, May 3-7 in Denver.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new University of Liverpool study, published in Wiley Brain and Behaviour, examines the factors that influence how a person adapts to visual field loss following stroke.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Troy A Tarpley, AAC Po Box 844658, Dallas, TX 75284-4658 Ph: (254) 724-8800 | Mr Troy A Tarpley, AAC 300 University Blvd, Round Rock, TX 78665-1032 Ph: (512) 509-0100 |
News Archive
Despite improvements in the past few decades with surgery, chemotherapy and radiation therapy, a predictably curative treatment for glioma does not yet exist. New insights into specific gene mutations that arise in this often deadly form of brain cancer have pointed to the potential of gene therapy, but it's very difficult to effectively deliver toxic or missing genes to cancer cells in the brain.
According to the Centers for Disease Control, the outbreak of Ebola in four West African countries is one of the largest outbreaks of the disease in history.
Andrew Tsin, professor of biology in the UTSA College of Sciences, has been named a Gold Fellow of the Association for Research in Vision and Ophthamology for his dedication and exemplary contributions in the field. Tsin will receive the honor at the 2015 ARVO Annual Meeting, May 3-7 in Denver.
Incyte Corporation today announced that its strategic collaborator, Novartis, received approval from the European Commission for Jakavi (INC424, ruxolitinib), an oral JAK 1 and JAK 2 inhibitor discovered by Incyte, for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis (also known as chronic idiopathic myelofibrosis), post-polycythemia vera myelofibrosis or post-essential thrombocythemia myelofibrosis.
A new University of Liverpool study, published in Wiley Brain and Behaviour, examines the factors that influence how a person adapts to visual field loss following stroke.
› Verified 9 days ago
Aneesa Patel, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 | |
Daniel Chen, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 | |
Timothy James Goodridge, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 Fax: 512-218-6330 | |
Haley Conn, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 300 University Blvd, Round Rock, TX 78665 Phone: 512-509-0100 | |
Mr. Paul C Mchorse, A.A.-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0200 | |
Courtney Alyson Weisbart, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 302 University Blvd, Round Rock, TX 78665 Phone: 512-509-0100 | |
Michael Leung, Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 300 University Blvd, Round Rock, TX 78665 Phone: 512-509-0100 |